Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May-Jun;100(3):539-547.
doi: 10.1016/j.abd.2024.09.010. Epub 2025 Apr 29.

Latin American consensus on psoriasis severity classification

Angela María Londoño-García  1 , Juan Raúl Castro-Ayarza  2 , Manuel Darío Franco Franco  3 , Cesar Fernando González Ardila  4 , Gabriel Magariños  5 , Enrique Salvador Rivas Zaldívar  6 , Susan Martínez  7 , Linda Ibatá  7 , Julieth Carolina Castillo  7 , Paola Jimena Cárdenas Rojas  3 , Evelyn Giuliana Castro Vargas  8 , Claudia Romina Contreras  9 , Carolina Ivette Cortes Correa  10 , Claudia de la Cruz Fernández  11 , Andrés Chavarriaga Restrepo  12 , Cristina Mariela Echeverria  13 , André Vicente Esteves de Carvalho  14 , Benjamín Hidalgo Matlock  15 , Enrique Loayza  16 , Matías Rafael Maskin  17 , Ricardo Romiti  18 , Fernando Valenzuela  19
Affiliations

Latin American consensus on psoriasis severity classification

Angela María Londoño-García et al. An Bras Dermatol. 2025 May-Jun.

Abstract

Background: There are different classifications of psoriasis based on its clinical presentation, impact on quality of life, requirements for specific treatments, and other patient- or physician-reported outcomes. However, the lack of unified definitions has led to the severity of the disease being underestimated. Standardizing the classification of psoriasis will promote a better approach to the disease and facilitate care by professionals.

Objective: To present a consensus of experts in Latin America regarding the classification of psoriasis severity, based on the best available evidence and applicable to current medical practice in the region.

Methods: An independent methodological team, together with a group of clinical dermatologists representatives from different Latin American countries, developed a consensus with a modified Delphi methodology based on a systematic review of the literature. This consensus includes the classification of psoriasis, tools to define the severity of psoriasis, and other considerations in evaluating patients with psoriasis.

Results: Fifteen statements were formulated aimed at classifying the severity of cutaneous psoriasis and other forms of the disease, as well as tools to assess and define the severity of psoriasis and therapy considerations. Additionally, the consensus addresses implementation considerations.

Conclusion: The results of this consensus constitute a solid basis for a standard classification terminology for the varied clinical forms of psoriasis and their therapeutic implications. The importance of maintaining a personalized therapeutic approach, adjusted to each country's available resources and administrative realities, is highlighted.

Keywords: Classification; Consensus; Delphi technique; Patient acuity; Psoriasis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest Angela Maria Londoño Garcia has been a speaker for Abbvie, Boehringer Ingelheim, Bristol, Eli Lilly, Janssen, Novartis, Pfizer. Juan Raúl Castro Ayarza has been a speaker for AbbVie, Amgen, Eli Lilly, Janssen, Novartis, and Pfizer. Manuel Darío Franco Franco has been a speaker for AbbVie, Amgen, Eli Lilly, Janssen, Novartis, Pharmalab, and Sanofi. Cesar Fernando González Ardila has been a speaker for: AbbVie, Boehringer Ingelheim, Eli Lilly, Janssen, and Novartis. Enrique Salvador Rivas Zaldivar has been a speaker for AbbVie and Novartis. Paola Jimena Cardenas Rojas has been a speaker for AbbVie, Amgen, Elli Lilly, and Janssen. Evelyn Giuliana Castro Vargas has been a speaker for AbbVie, Janssen and Tecnofarma. Andrés Chavarriaga Restrepo has been a speaker for Amgen, Eli Lilly, Janssen, Novartis, Pfizer, Pharmalab. Carolina Ivette Cortes Correa has been a speaker for Eli Lilly, Novartis, Bristol, Janssen. Claudia de la Cruz Fernández has been a speaker or researcher for AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Janssen, Novartis, Pfizer, Sandoz, UCB Pharma. Cristina Mariela Echeverria has been a speaker for AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Janssen, L'Oreal, Novartis, Pfizer, Sandoz, UCB Pharma. André Vicente Esteves de Carvalho has been a speaker for AbbVie, Boehringer Ingelheim, Eli Lilly, Janssen and Novartis. Benjamin Hidalgo Matlock has been a researcher for Cutera and Novartis. Enrique Fabian Loaiza Sánchez has been a speaker for Janssen, Medicament, and Novartis. Ricardo Romiti has been a speaker for AbbVie, Boehringer, Eli Lilly, Janssen, LEO Pharma, Novartis, Teva and UCB. Fernando Valenzuela has been a speaker for AbbVie, Boehringer Ingelheim, Eli Lilly, Jannsen, LEO, and Novartis. Other authors do not declare conflicts of interest.

Figures

Figure 1
Figure 1
Consensus development on modified Delphi methodology.
See this image and copyright information in PMC

References

    1. Griffiths C.E.M., Armstrong A.W., Gudjonsson J.E., Barker J.N.W.N. Psoriasis. Lancet. 2021;397:1301–1315. doi: 10.1016/S0140-6736(20)32549-6. - DOI - PubMed
    1. Armstrong A.W., Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323:1945–1960. - PubMed
    1. Puig L., Bordas X., Carrascosa J.M., Daudén E., Ferrándiz C., Hernanz J.M., et al. [Consensus document on the evaluation and treatment of moderate-to-severe psoriasis. Spanish psoriasis group of the Spanish Academy of Dermatology and Venereology] Actas Dermosifiliogr. 2009;100:277–286. - PubMed
    1. Strober B., Ryan C., van de Kerkhof P., van der Walt J., Kimball A.B., Barker J., et al. Recategorization of psoriasis severity: Delphi consensus from the International psoriasis council. J Am Acad Dermatol. 2020;82:117–122. - PubMed
    1. Gisondi P., Altomare G., Ayala F., Bardazzi F., Bianchi L., Chiricozzi A., et al. Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis. J Eur Acad Dermatol Venereol. 2017;31:774–790. - PubMed

Publication types

LinkOut - more resources